Quantum BioPharma
QNTM

Quantum BioPharma (QNTM) earnings history

Most recent quarter

Period end
Dec 31, 2025
EPS actual
−$0.19
EPS estimate
−$1.02
Revenue
$0.00
Reported
Mar 26, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q4 2025Mar 26, 2026−$1.02−$0.19+81.19%$0.00SEC
Q3 2025Nov 6, 2025−$2.66−$1.26+52.49%$0.00SEC
Q2 2025Aug 7, 2025−$0.17−$3.27−1824.04%$0.00SEC
Q1 2025May 14, 2025−$0.62−$3.42−447.94%$2.1MSEC
Q4 2024Mar 28, 2025−$0.78−$2.78−256.92%$0.00SEC
Q3 2024Nov 12, 2024−$2.77−$2.88−3.90%$0.00SEC
Q2 2024Invalid Date−$3.89−$0.08+97.97%$0.00
Q1 2024May 15, 2024−$3.28−$3.27+0.28%$0.00SEC
Q4 2023Apr 2, 2024−$9.31−$2.68+71.24%$0.00SEC
Q3 2023Nov 15, 2023−$9.09−$1.95+78.53%$0.00SEC
Q2 2023Jul 20, 2023$0.00−$9.31+0.00%$0.00SEC
Q3 2021Nov 15, 2021$0.00−$9.57+0.00%$0.00
Q2 2021Aug 13, 2021$0.00−$22.88+0.00%$0.00
Q3 2020Nov 16, 2020−$40.18−$68.74−71.08%$0.00
Q2 2020Aug 11, 2020$0.00$27.53+0.00%$6.1B

Quarterly revenue

Q2 2020
$6.1B
Q3 2020
$0.00
Q2 2021
$0.00
Q3 2021
$0.00
Q2 2023
$0.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$2.1M
Q2 2025
$0.00
Q3 2025
$0.00
Q4 2025
$0.00

Frequently asked questions

  • When did Quantum BioPharma (QNTM) last report earnings?

    Quantum BioPharma last reported on Mar 26, 2026, covering fiscal Q4 2025.

  • Did QNTM beat earnings estimates?

    Yes. Quantum BioPharma reported EPS of −$0.19 for Q4 2025 against a −$1.02 estimate — a 81.19% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.